All the top Biotech & Pharma news in one daily newsletter.

Want to understand how these updates are formatted? Check-out the FAQ.

Have any feedback? I’d love to hear you from - connect with me on LinkedIn. 📣

THE GOOD
Clinical Trials

Cellphire Therapeutics' CLPH-511, a cryopreserved platelet product, met primary efficacy endpoint in Ph2/3 trial for uncontrolled hemorrhage during cardiopulmonary bypass surgery
Platelet-derived product, uncontrolled hemorrhage - Read more

Ascletis Pharma reports positive Ph1b results for ASC30, a GLP-1R agonist oral tablet, showing up to 6.5% weight reduction in obesity patients
GLP-1, obesity - Read more

PRESENTED BY TLDR BIOTECH
What would you do with 7k+ meticulously tagged biotech & pharma data points?
Free gene-editing data set below!

Over the past year, TLDR Biotech has been collecting and categorizing industry news across approvals, clinical trials, fundraises, partnerships, M&A, politics & policy, and much much more.

Each data point is tagged by drug modality, disease indication, tech area, and even more specific categories. For example:

🔍 Need to track all small molecule fundraises across oncology?

📈 Want a curated list of recent cell therapy clinical trials updates (both the successes and failures)?

💡 Looking for trends in Alzheimer's and Parkinson's disease partnerships?

Here’s a free set of data - gene-editing stories over the last 4 months.

We’re leveraging this resource to build tailored reports and curated insights for select clients—and now you can get full access.

Ready to get access or have questions? Check out our landing page.

✅ More Good News ✅

THE GOOD
Fundraises

Sirona Biochem secures $3M CAD ($2.17M USD) investment and joint venture with Promura for drug discovery development
Drug discovery, aesthetic medicine - Read more

GenrAb $5.6M Seed, developing neuroprotective therapies with focus on TGM-010 antibody for neurodegenerative diseases
Antibody, neurology, neuroprotection - Read more

Field Medical raises $40M in Series A funding for cardiac pulsed field ablation technology to treat heart arrhythmias
Medical countermeasures, pulsed field ablation, cardiac arrhythmia - Read more

Biolinq $100M Series C, developing intradermal biosensor platform for glucose monitoring with activity tracking
Medical device, continuous glucose monitoring, diabetes - Read more

THE GOOD
Investments

Roche pledges $50B to expand US drug production, creating 12,000 jobs amid tariff threats from Trump administration
Domestic manufacturing, tariffs, big pharma strategy -Read more

THE GOOD
Lawsuits

Walgreens agreed to pay $300M to DOJ for illegally filling opioid prescriptions, with additional $50M contingent on company changes
Opioid epidemic, opioid, opioid epidemic suit - Read more

THE GOOD
Mergers & Acquisitions

Alumis and Acelyrin revised merger terms, increasing exchange ratio to 0.4814:1, shifting ownership balance to 52% Alumis, 48% Acelyrin
Monoclonal antibody, small molecule, plaque psoriasis, thyroid eye disease - Read more

KKR offers to acquire Swedish life sciences company Biotage for $1.2bn, with board recommending shareholders accept.
Equipment/Instrumentation - Read more

THE GOOD
Partnerships

Regeneron Pharmaceuticals, Fujifilm Diosynth Biotechnologies, $3bn partnership to double US manufacturing capacity for biologics
Manufacturing partnership, biologics manufacturing - Read more

SOMAÍ, SHERBINSKIS, BOUTIQ, exclusive partnership to manufacture and distribute medical cannabis products across Europe and Australia
Cannabinoid, distributon partnership - Read more

THE GOOD
Politics & Policy

AstraZeneca rejoins PhRMA lobbying group after two-year absence amid potential tariffs and increased US manufacturing investments
Lobbying, domestic manufacturing, tariffs - Read more

Arkansas passes law banning PBMs from owning pharmacies, sparking debate and similar bills in other states
Pharmacy, pharmacy benefit managers - Read more

THE GOOD
Product Launches

BD launches HemoSphere Alta monitor with AI to predict blood pressure changes during surgery - “first major product launch” from Edwards Lifesciences acquisition
Medical device, AI, blood pressure monitoring - Read more

THE GOOD
Strategic Plans

Pharmaceutical companies stockpiling drugs in US to mitigate anticipated Trump tariffs while considering long-term manufacturing adjustments.
Big pharma strategy, tariffs, supply chain - Read more

THE BAD
Clinical Trials

Bristol Myers Squibb's Cobenfy (xanomeline/trospium chloride), an M1/M4 muscarinic receptor agonist, failed Ph3 trial as add-on therapy for schizophrenia.
Small molecule, schizophrenia - Read more

THE BAD
Earnings & Finances

Danaher faces $350M tariff impact but plans mitigation through regional manufacturing, pricing strategies, and $150M cost savings.
Equipment/Instrumentation, tariffs - Read more

THE BAD
Public Health

Biden-era Project NextGen halts vaccine trials by GeoVax, Castlevax, and Vaxart amid HHS restructuring under Robert F. Kennedy Jr.
Vaccine, pandemic preparedness, public funding, vaccine hesitancy - Read more [Paywall]

THE UGLY
Lawsuits

Harvard sues Trump administration over $2.2 billion funding freeze affecting research, claiming government overreach into academic decisions
Public funding suit, federal research funding - Read more

Sam Waksal, previously convicted of insider trading, now sued for alleged fiduciary breaches and administering unapproved drugs to a child
Smuggling, Illegal importation, reckless acts - Read more [Paywall]

THE UGLY
Politics & Policy

Trump administration revisits plan to tie US drug prices to lower prices in other countries, concerning pharmaceutical industry
Drug pricing - Read more

THE UGLY
Regulatory

FDA staff cuts delay hearing decision for Vanda Pharmaceuticals' drug tradipitant by months, affecting appeals process
Drug approval process - Read more [Paywall]

You’re all caught up on the latest Pharma & Biotech News!

TLDR Biotech wants to hear from you! 📣

Have comments/questions/complaints about this newsletter?
Send me an email - I want your brutally honest feedback. 📝

Last thing - if you find the content useful and think a colleague would too, please share TLDR Biotech with them! ♻️

Disclaimer: Content, news, research, tools, and mention of stock or tradeable securities are for educational and illustrative purposes only and do not imply a recommendation or solicitation to buy or sell a particular security or to engage in any particular investment strategy. Read the full terms & conditions here